|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 慢性乙肝患者阿德福韦治疗的病毒学应答和耐药性显示文摘背景:HBV感染患者的阿德福韦耐药性发生率和危险因素尚未明确。目的:探讨阿德福韦病毒学应答的特征、明确阿德福韦耐药的发生率并研究起始病毒学应答(Initial Virologic Response,IVR)和阿德福韦耐药的相关因素。 | Fung SK Chae HB Fontana RJ | 2006 | 中国处方药2006，5，3： | 63 |
| 2 | Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics显示文摘The potential for the positive manipulation of the gut microbiome through the introduction of beneficial microbes, as also known as probiotics, is currently an active area of investigation. The FAO/WHO define probiotics as live microorganisms that confer a health benefit to the host when administered in adequate amounts. However, dead bacteria and bacterial molecular components may also exhibit probiotic properties. The results of clinical studies have demonstrated the clinical potential of probiotics in many pathologies, such as allergic diseases, diarrhea, inflammatory bowel disease and viral infection. Several mechanisms have been proposed to explain the beneficial effects of probiotics, most of which involve gene expression regulation in specific tissues, particularly the intestine and liver. Therefore, the modulation of gene expression mediated by probiotics is an important issue that warrants further investigation. In the present paper, we performed a systematic review of the probiotic-mediated modulation of gene expression that is associated with the immune system and inflammation. Between January 1990 to February 2014, Pub Med was searched for articles that were published in English using the Me SH terms 'probiotics ' and ' gene expression ' combined with 'intestines', 'liver', 'enterocytes', 'antigen-presenting cells', 'dendritic cells', 'immune system', and 'inflammation'. Two hundred and five original articles matching these criteria were initially selected, although only those articles that included specific gene expression results(77) were later considered for this review and separated into three major topics: the regulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver. Particular strains of Bifidobacteria, Lactobacilli, Escherichia coli, Propionibacterium, Bacillus and Saccharomyces influence the gene expression of mucins, Toll-like receptors, caspases, nuclear factor-κB, and interleukins and lead mainly to an anti-inflammatory response in cultured enterocytes. In addition, the interaction of commensal bacteria and probiotics with the surface of antigenpresenting cells in vitro results in the downregulation of pro-inflammatory genes that are linked to inflammatory signaling pathways, whereas other anti-inflammatory genes are upregulated. The effects of probiotics have been extensively investigated in animal models ranging from fish to mice, rats and piglets. These bacteria induce a tolerogenic and hyporesponsive immune response in which many genes that are related to the immune system, in particular those genes expressing anti-inflammatory cytokines, are upregulated. By contrast, information related to gene expression in human intestinal cells mediated by the action of probiotics is scarce. There is a need for further clinical studies that evaluate the mechanism of action of probiotics both in healthy humans and in patients with chronic diseases. These types of clinical studies are necessary for addressing the influence of these microorganisms in gene expression for different pathways, particularly thosethat are associated with the immune response,and to better understand the role that probiotics might have in the prevention and treatment of disease. | Julio Plaza-Diaz Carolina Gomez-Llorente Luis Fontana Angel Gil | 2014 | World Journal of Gastroenterology2014，20，42： | 12 |
| 3 | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C显示文摘 | Chun-Tao Wai Joel K. Greenson Robert J. Fontana John D. Kalbfleisch Jorge A. Marrero Hari S. Conjeevaram Anna S.-F. Lok | 2003 | Hepatology2003，，2： | 11 |
| 4 | Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C显示文摘 | R. J. Fontana E. A. Hughes M. Bifano H. Appelman D. Dimitrova R. Hindes W. T. Symonds | 2013 | American Journal of Transplantation2013，，6： | 7 |
| 5 | Separation of middle rare earths by solvent extraction using 2-ethylhexylphosphonic acid mono-2-ethylhexyl ester as an extractant显示文摘The extraction of the trivalent middle rare earths from chloride media by kerosene solutions of 2-ethylhexylphosphonic acid mono-2-ethylhexyl ester as an extractant was studied. The separation factors between the elements using solution simulating wastes from NiMH spent batteries have been evaluated: the order of the extractive ability of extractant can be confirmed in Tb>Gd>Eu>Sm. | Danilo Fontana Loris Pietrelli | 2009 | Journal of Rare Earths2009，27，5： | 7 |
| 6 | Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B显示文摘 | A. K. Singal H. Salameh Y.‐F. Kuo R. J. Fontana | 2013 | Aliment Pharmacol Ther2013，，2： | 6 |
| 7 | 对乙酰氨基酚引起的急性肝衰竭:一项美国多中心前瞻性研究结果显示文摘Severe acetaminophen hepatotoxicity frequently leads to acute liver failure (ALF). We determined the incidence, risk factors, and outcomes of acetaminophen- induced ALF at 22 tertiary care centers in the United States. Detailed prospective data were gathered on 662 consecutive patients over a 6- year period fulfilling standard criteria for ALF (coagulopathy and encephalopathy), from which 275 (42% )were determined to result from acetaminophen liver injury. The annual percentage of acetaminophen-related ALF rose during the study from 28% in 1998 to 51% in 2003. Median dose ingested was 24 g (equivalent to 48 extra-strength tablets). Unintentional overdoses accounted for 131 (48% ) cases, intentional (suicide attempts) 122 (44% ), and 22 (8% ) were of unknown intent. In the unintentional group, 38% took two or more acetaminophen preparations simultaneously, and 63% used narcotic-containing compounds. Eighty-one percent of unintentional patients reported taking acetaminophen and/or other analgesics for acute or chronic pain syndromes. Overall, 178 subjects (65% ) survived, 74 (27% ) died without transplantation, and 23 subjects (8% ) underwent liver transplantation; 71% were alive at 3 weeks. Transplant free survival rate and rate of liver transplantation were similar between intentional and unintentional groups. In conclusion, acetaminophen hepatotoxicity far exceeds other causes of acute liver failure in the United States. Susceptible patients have concomitant depression, chronic pain, alcohol or narcotic use, and/or take several preparations simultaneously. Education of patients, physicians, and pharmacies to limit high-risk use settings is recommended. | Larson A.M. Polson J. Fontana R.J. 宋平 | 2006 | 世界核心医学期刊文摘(胃肠病学分册)2006，2，8： | 5 |
| 8 | Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy显示文摘AIM:To evaluate a levofloxacin-doxycycline-based triple therapy with or without a susceptibility culture test in non-responders to Helicobacter pylori(H.pylori) eradication.METHODS:A total of 142(99 women,43 men; mean 53.0 ± 12.7 years) non-responders to more than two H.pylori eradication therapies underwent susceptibility culture tests or were treated with a seven-day triple therapy consisting of esomeprazole,20 mg b.i.d.,levofloxacin,500 mg b.i.d.,and doxycycline,100 mg b.i.d.,randomly associated with(n = 71) or without(n = 71) Lactobacillus casei DG.H.pylori status was checked in all patients at enrollment and at least 8 wk after the end of therapy.Compliance and tolerability of regimens were also assessed.RESULTS:H.pylori eradication was achieved in < 50% of patients [per prototol(PP) = 49%; intention to treat(ITT) = 46%].Eradication rate was higher in patients administered probiotics than in those without(PP = 55% vs 43%; ITT = 54% vs 40%).Estimated primary resistance to levofloxacin was 18% and multiple resistance was 31%.Therapy was well tolerated,and side effects were generally mild,with only one patient experiencing severe effects.CONCLUSION:Third-line levofloxacin-doxycycline triple therapy had a low H.pylori eradication efficacy,though the success and tolerability of this treatment may be enhanced with probiotics. | Omero Alessandro Paoluzi Giovanna Del Vecchio Blanco Emanuela Visconti Manuela Coppola Carla Fontana Marco Favaro Francesco Pallone | 2015 | World Journal of Gastroenterology2015，21，21： | 5 |
| 9 | Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes显示文摘In the past 10 years the prevalence of type 2 diabetes mel itus(T2DM) has increased hugely worldwide,driven by a rise in the numbers of overweight and obese individuals.A number of diets have been shown to be effective for the management of T2DM:the Mediterranean diet,the vegetarian diet and the low-calorie diet.Results of studies clearly indicate,however,that the efficacy of these diets is not solely related to the biochemical structure of the individual nutrients they contain.This review discusses this point with reference to the potential role of the intestinal microbiota in diabetes.The macrobiotic Ma-Pi 2 diet is rich in carbohydrates,whole grains and vegetables,with no animal fat or protein or added sugar.In shortand medium-term trials conducted in patients with T2 DM,the Ma-Pi 2 diet has been found to significantly improve indicators of metabolic control,including fasting blood glucose,glycosylated hemoglobin,the serum lipid profile,body mass index,body weight and blood pressure.The diet may also alter the gut microbiota composition,which could additionally affect glycemic control.As a result,the Ma-Pi 2 diet could be considered a valid additional shortto medium-term treatment for T2 DM. | Francesco Fallucca Lucia Fontana Sara Fallucca Mario Pianesi | 2015 | World Journal of Diabetes2015，6，3： | 3 |
| 10 | Long‐term outcome of hepatitis B virus‐related C hronic H epatitis under protracted nucleos(t)ide analogues显示文摘 | G. A. Niro A. M. Ippolito R. Fontana M. R. Valvano D. Gioffreda A. Iacobellis A. Merla M. Durazzo G. Lotti L. Di Mauro A. Andriulli | 2013 | J Viral Hepat2013，，7： | 3 |
| 11 | Genetics of barley tiller and leaf development显示文摘In cereals, tillering and leaf development are key factors in the concept of crop ideotype, introduced in the 1960 s to enhance crop yield, via manipulation of plant architecture. In the present review, we discuss advances in genetic analysis of barley shoot architecture,focusing on tillering, leaf size and angle. We also discuss novel phenotyping techniques, such as 2 D and 3 D imaging, that have been introduced in the era of phenomics, facilitating reliable trait measurement. We discuss the identification of genes and pathways that are involved in barley tillering and leaf development,highlighting key hormones involved in the control of plant architecture in barley and rice. Knowledge on genetic control of traits related to plant architecture provides useful resources for designing ideotypes for enhanced barley yield and performance. | Salar Shaaf Gianluca Bretani Abhisek Biswas Irene Maria Fontana Laura Rossini | 2019 | Journal of Integrative Plant Biology2019，61，3： | 3 |
| 12 | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C显示文摘 | Chun-Tao Wai Joel K. Greenson Robert J. Fontana John D. Kalbfleisch Jorge A. Marrero Hari S. Conjeevaram Anna S.-F. Lok | 2003 | Hepatology2003，，2： | 3 |
| 13 | Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting显示文摘 | Sarah Tischer Robert J. Fontana | 2013 | Journal of Hepatology2013，，： | 3 |
| 14 | Clinical and molecular spectrum of Wiedemann-Steiner syndrome, an emerging member of the chromatinopathy family显示文摘Wiedemann-Steiner syndrome(OMIM#605130)is a rare congenital malformation syndrome characterized by hypertrichosis cubiti associated with short stature;consistent facial features,including long eyelashes,thick or arched eyebrows with a lateral flare,wide nasal bridge,and downslanting and vertically narrow palpebral fissures;mild to moderate intellectual disability;behavioral difficulties;and hypertrichosis on the back.It is caused by heterozygous pathogenic variants in KMT2A.This gene has an established role in histone methylation,which explains the overlap of Wiedemann-Steiner syndrome with other chromatinopathies,a heterogeneous group of syndromic conditions that share a common trigger:The disruption of one of the genes involved in chromatin modification,leading to dysfunction of the epigenetic machinery. | Paolo Fontana Francesco Fioravanti Passaretti Marianna Maioli Giuseppina Cantalupo Francesca Scarano Fortunato Lonardo | 2020 | World Journal of Medical Genetics2020，9，1： | 2 |
| 15 | HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption显示文摘 | Ioanna Papandreou Rob A. Cairns Lucrezia Fontana Ai Lin Lim Nicholas C. Denko | 2006 | Cell Metabolism2006，，3： | 2 |
| 16 | Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation显示文摘 | Michael Charlton Edward Gane Michael P. Manns Robert S. Brown Michael P. Curry Paul Y. Kwo Robert J. Fontana Richard Gilroy Lewis Teperman Andrew J. Muir John G. McHutchison William T. Symonds Diana Brainard Brian Kirby Hadas Dvory-Sobol Jill Denning Sara | 2014 | Gastroenterology2014，，： | 2 |
| 17 | Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct显示文摘 | Fontana Robert J Watkins Paul B Bonkovsky Herbert L Chalasani Naga Davern Timothy Serrano Jose Rochon James | 2009 | Drug Safety2009，，1： | 2 |
| 18 | Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients显示文摘 | Jorge A. Marrero Grace L. Su Wei Wei Dawn Emick Hari S. Conjeevaram Robert J. Fontana Anna S. Lok | 2003 | Hepatology2003，，5： | 2 |
| 19 | Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States显示文摘 | Naga Chalasani Robert J. Fontana Herbert L. Bonkovsky Paul B. Watkins Timothy Davern Jose Serrano Hongqiu Yang James Rochon | 2008 | Gastroenterology2008，，6： | 2 |
| 20 | NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States显示文摘 | Jorge A. Marrero Robert J. Fontana Grace L. Su Hari S. Conjeevaram Dawn M. Emick Anna S. Lok | 2002 | Hepatology2002，，6： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员